Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0.0022 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0053 | 0.0974 | 0.1639 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0479 | 0.0755 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0479 | 0.0755 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.0952 | 0.1499 |
Brugia malayi | MAP kinase sur-1 | 0.0053 | 0.0974 | 0.1535 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.0952 | 0.1499 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0022 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.0022 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0022 | 0.5 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0022 | 0.0035 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.002 | 0.0014 | 0.0014 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.0022 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0053 | 0.0974 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0053 | 0.0974 | 1 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.002 | 0.0014 | 0.0022 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0053 | 0.0974 | 1 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0229 | 0.5945 | 0.5945 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0229 | 0.5945 | 0.9363 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0053 | 0.0974 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.002 | 0.0014 | 0.0023 |
Echinococcus multilocularis | expressed protein | 0.0372 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0105 | 0.2441 | 0.3844 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0479 | 0.0806 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0022 | 0.0022 |
Brugia malayi | follicle stimulating hormone receptor | 0.0243 | 0.6349 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0053 | 0.0974 | 0.1535 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.0952 | 0.1499 |
Trypanosoma brucei | protein kinase, putative | 0.0053 | 0.0974 | 1 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0243 | 0.6349 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.002 | 0.0022 | 0.5 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0022 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0053 | 0.0974 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0022 | 0.0022 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0022 | 0.0225 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0229 | 0.5945 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0053 | 0.0974 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0022 | 0.0037 |
Brugia malayi | Cytochrome P450 family protein | 0.0049 | 0.0858 | 0.1352 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0053 | 0.0974 | 0.0974 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0053 | 0.0974 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0053 | 0.0974 | 0.0974 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0053 | 0.0974 | 0.0974 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0229 | 0.5945 | 0.5945 |
Loa Loa (eye worm) | AGC/GRK/BARK protein kinase | 0.002 | 0.0014 | 0.0022 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0053 | 0.0974 | 1 |
Echinococcus granulosus | beta-adrenergic receptor kinase | 0.002 | 0.0014 | 0.0014 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.002 | 0.0014 | 0.0022 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0053 | 0.0974 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0022 | 0.0037 |
Schistosoma mansoni | serine/threonine protein kinase | 0.002 | 0.0014 | 0.0023 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0053 | 0.0974 | 0.0974 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0022 | 0.0035 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0053 | 0.0974 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0952 | 0.1499 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0053 | 0.0974 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0053 | 0.0974 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0049 | 0.0858 | 0.1352 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0053 | 0.0974 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.002 | 0.0014 | 0.0023 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0022 | 0.0225 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | NA 0 uM | Inhibition of H+/K+ ATPase from porcine gastric mucosal membrane vesicles | ChEMBL. | 8558532 |
Inhibition (functional) | = 0 % | Gastric antisecretory activity was tested in rats at 30 mg/kg, po expressed as the percentage of inhibition against the acid output of the control group | ChEMBL. | 8558532 |
Inhibition (functional) | = 0 % | Gastric antisecretory activity was tested in rats at 30 mg/kg, po expressed as the percentage of inhibition against the acid output of the control group | ChEMBL. | 8558532 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.